Projects

nanoimmunotech is involved in several projects that are listed below.

H2020

NEW DEAL

New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinase 3 (H2020-NMBP-2016)

Inflammatory bowel diseases (IBD) are the second most common immune-mediated disorders in Europe, affecting more particularly young people. The current therapies, including antibodies, show three main drawbacks: efficacy, tolerability and convenience. NEW DEAL solution will offer radical therapeutic progress for all IBD patients, thanks to the improved efficacy and increased safety of the specific JAK3 inhibition, which has been proven in clinics to be a target of great interest, the better tolerability of siRNA in term of immunogenicity and the good convenience with oral administration. Read more >> 

newdeal


BIOCAPAN

Bioactive implantable capsule for pancreatic islets immunosuppression free therapy (H2020-NMP-2014-2; 646272)

The company´s main contribution is related to validation, nanosafety characterization and standardization (in vitro and in vivo) of the use of new biomaterials and nanomatrices for nanoencapsulation of pancreatic islets. VISIT WEBSITE >>

 


MARISURF


Novel, sustainable marine bio-surfactant/bio-emulsifiers for commercial exploitation

nano
immunotech
´s main contribution is related to validation and nanosafety characterization (in vitro and in vivo) of the use of new surfactants in nanoparticle synthesis for pharma applications. VISIT WEBSITE >>

logo MARISURF EU flag



HEATSENS-S


Lab-on-a-chip microfluidic device based on plasmonic driven thermal for rapid detection of Salmonella typhimurium in agro-food field (H2020-SMEINST-1-2014)

HEATSENS is based on a revolutionary nanobiosensing technology owned by the company, whose main characteristics (highly sensitive, rapid detection and simplicity) are the ideal response to a clear need in this sector to test for Salmonella.

Salmonellosis is the second most commonly reported gastrointestinal infection, requiring hospitalization in many cases, and it can be fatal. One of the most common ways of contracting it is by eating contaminated chicken meat; thus meat companies are required to carry out periodic tests, for which they send samples to specialist laboratories that have a response time of up to 7 days for the analyses, which may mean financial losses.

Given that this technology fits into the NIT development strategy, it was decided to perform proofs of concept with several companies in the sector, which clearly showed that HEATSENS_S detects Salmonella at a higher sensitivity in only 3 hours. In light of these results, these potential customers have already shown their keen interest in HEATSENS_S.

Now, its conversion into an easy-to-use portable device makes performing in-house testing possible throughout the production chain, providing companies with greater control over product quality and avoiding losses associated with contamination not detected in time, all at a lower cost than current test today.

NIT Management considers this to be the optimum catalyst for the growth of the company and its expansion worldwide and HEATSENS, the flagship product, to make their efforts profitable in nanobiosensing.

smes in horizon 2020 european comission

This project has received funding from the European Union´s Horizon 2020 Research and Innovation Programme under grant agreement Nº 733617

FP7



NAREB


Nanotherapeutics for antibiotic resistant emerging bacterial pathogens (FP7-NMP-2013-LARGE-7; 604237)

The company´s main contribution is related to physicochemical characterization of nanodelivery sistems, biological and immunological characterization, both in vitro and in vivo, and biodistribution in order to test the safety of the nanosystems developed and to validate cell targeting. VISIT WEBSITE >>

logo NAREB EU flag



NATIONALS



ALISEG


Incremento de la seguridad alimentaria en mercados nacionales e internacionales a través del desarrollo de nuevas tecnologías y procesos sostenibles e innovadores

nano
immunotech
 
is participating in this project with HEATSENS technology. The main objective is to ensure food security through research, innovation and development of new products and processes, preserving the natural resources and reducing the need for energy in the meat transformation processes.


This proyect FEDER Innterconecta 2015 Pluri-Regional has been funded by  Centro para el Desarrollo Tecnológico Industrial (CDTI),
with the support of  Ministerio de Economía y Competitividad, and co-funded by Fondo Europeo de Desarrollo Regional  (FEDER), under the Programa Operativo de Crecimiento Inteligente FEDER 2014-2020.

 logo-CDTI LOGO FEDER es COLOR1 


SF4SF

Smart Factory for Safe Foods

The aim of this proyect FEDER Innterconecta 2015 is to raise the productivity of the factory and product safety by eliminating microbiological risk and allergens. nanoimmunotech contributes with HEATSENS technology.

sf4sf

) participa en el proyecto “ALISEG – Incremento de la seguridad alimentaria en mercados nacionales e internacionales a través del desarrollo de nuevas tecnologías y procesos sostenibles e innovadores” cuyo objetivo principal es garantizar la seguridad alimentaria mediante la investigación, la innovación y el desarrollo de nuevos productos y procesos, avanzando en la conservación de los recursos naturales y disminuyendo la necesidad de energía de los procesos de transformación de la carne.

Este proyecto FEDER Innterconecta 2015 Pluri-Regional ha sido subvencionado por el Centro para el Desarrollo Tecnológico Industrial (CDTI) con el apoyo del Ministerio de Economía y Competitividad, y cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER), dentro del Programa Operativo de Crecimiento Inteligente FEDER 2014-2020


HELLOKIT

Desarrollo de un kit universal para liberación remota controlada de fármacos mediante hipertermia magnética en aplicaciones oncológicas

nano
immunotech
participates in the project "Desarrollo de un kit universal para liberación remota controlada de fármacos mediante hipertermia magnética en aplicaciones oncológicas", IPT-2012-0712-010000, developed in collaboration with the entities NANOSCALE BIOMAGNETICS, ORYZON GENOMICS, NANOIMMUNOTECH, FUNDACIÓN DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE, UNIVERSIDAD DE ZARAGOZA, that is being funded by the Ministerio de Economía y Competitividad, within the Plan Nacional de Investigación Científica, Desarrollo e Innovación Tencológica 2008-2011, under the Programa Nacional de Cooperación Público-Privada - subprograma INNPACTO.

 
logo hellokit

SENSO3

Eliminación de contaminantes en aguas residuales urbanas mediante ozonización controlada mediante biosensores

nano
immunotech
participates in the project "Eliminación de contaminantes en aguas residuales urbanas mediante ozonización controlada mediante biosensores", IN852A 2016/55. Within the Programme ConectaPEME 2016, the project consortium is led by nanoimmunotech having as partners TAYSUNAVE, SYSPRO y GESECO AGUAS. AIMEN participates as collaborating entity.

The main objective of this project is the development of an ozonation treatment system for microcontaminants in water and its monitoring and control by optical biosensors based on gold nanoprisms, in order to optimize their elimination, minimizing maintenance and operation costs. The biosensor is based on HEATSENS technology from nanoimmunotech.

SENSO3 con titulo
Logo financiancionSENSO3

LOCATIONS

HEADQUARTERS IN VIGO
Edificio CITEXVI
Fonte das Abelleiras s/n
Campus Universitario de Vigo
36310 Vigo, Pontevedra, Spain

HEADQUARTERS IN ZARAGOZA
Fernando de Antequera, 2 Local D
50006 Zaragoza, Spain

FLICKR

Scroll to Top